Fordras, a Swiss company, has been serving the pharmaceutical and food industries since 1983.
Fordras’ international experience in the sales of active pharmaceutical ingredients and food additives makes it one of the leading companies in the marketing of organic enzymes such as Lysozyme.
At Fordras, our mission is to sell natural products aimed at improving people’s health and at enhancing the way foods are processed and preserved.
Fordras is the commercial branch for Bioseutica‘s pharmaceutical ingredients.
The company’s headquarters are located in Lugano, Switzerland. They comprise of commercial offices, Quality Control, and a Research & Development Center. Manufacturing plants are located in Denmark, Germany, Holland and Venezuela.
The production facilities are located in Holland, Germany, Denmark, and Venezuela. The equipment is strategically placed at egg processing facilities in order to guarantee continuous access to fresh, traceable raw material (albumin) and to enhance logistics and cost savings.
The production process follows GMP guidelines. The plant located in Nuspeet, Holland has recently received its GMP certification from the Dutch authorities for production of active pharmaceutical ingredients.
The original production method of Lysozyme was originally developed by Prof. Rodolfo Ferrari and his team of researchers at SPA Società Prodotti Antibiotici.
Fordras SA is a Bioseutica Group company.
Research & Development
Fordras S.A. finds its origin in the R&D tradition of SOLAR CHEMICAL S.A., a group of European chemical companies, which, over the years, has led to the filing of numerous patents throughout the world.
Our competitive edge comes in great part from our ability to remain at the forefront of innovation through proprietary products, technologies, and applications, having invested from the inception in important resources toward research and development. Consequently, Fordras S.A. holds several patents and patents pending on a broad range of applications for egg-derived proteins and other biological products. In fact, Fordras was the first company to recognize the value of Lysozyme in the food industry by developing its’ application in dairy products, particularly in the process of cheese making.
Later, Fordras S.A. and its world-class staff of scientists and researchers led the way in developing the use of Lysozyme in winemaking and brewing. Through these efforts, Fordras was able to obtain important use patents associated with the application of Lysozyme in fermented beverages.
Currently, Fordras continues to lead the way by financing new research programs, in- house as well as at prestigious institutions such as Oregon State University, UniversitÃ¡ di Udine, ITV France, AWRI (Australian Wine Research Institute) and The University of Wisconsin. In early 2005, one of Fordras’ sponsored research program at OSU, (which focused on the use of Lysozyme in food packaging and coating materials), led to the development of proprietary technology in that field.
Additionally, Fordras S.A. has been a forerunner in developing the use of Avidin as a marker in the treatment of cancer. This particular research program, initiated in 1994 in collaboration with the European Institute of Oncology, is entering its final phase this year. This revolutionary radioimmunology technique “which has shown virtually no toxicity, has successfully been applied to the treatment of brain cancer called gliobastoma1“
Current and future research programs are dedicated to the development of new applications for Lysozyme, Avidin, and Ovalbumin for human and animal health, in consumer products and in the food markets, as well as to the production and use of additional synergic natural products.
At Fordras we believe that in order to successfully bring one’s R&D pipeline to market, it is necessary to establish a rigorous and effective Regulatory program. In this case, once again Fordras has been the leader. Through the strength of its’ pharmaceutical background along with sensitivity to the safety needs of the consumers, Fordras often anticipated government regulations. As shown in the timetable below, Fordras was the first company to obtain important recognitions and approval from governmental agencies and organizations, including GRAS status. Today, Fordras remains the only company with a Drug Master File for the use of Lysozyme in pharmaceutical applications. Recently, thanks to Fordras’ efforts, Lysozyme was approved for use in organic products by the USDA.
Marketing & Distribution
At Fordras, we believe our customers are our most important assets. Consequently, we strive to provide them with products of the highest quality, with innovative applications and the best customer service.
Our products are marketed and distributed worldwide, directly or through a network of highly reputable distributors for each industry we serve.
Due to the versatility of our products in general, and of Lysozyme in particular, Fordras serves customers in several industries that require different expertise for their individual needs. Fordras rises to the challenge by maintaining on-staff experts in each attended market. These skilled professionals interact with our distributors and/or directly with the end-users, to address each and every question that they might have.
In cheese making, for example, we offer complete customer service for the Artisinal and Specialty cheesemaker, with testing of milk for Clostridium tyrobutyricum at the Vermont Institute of Artisinal Cheese in Burlington and at our laboratory in Lugano, Switzerland. We provide a complete and accurate diagnosis with dosage recommendations based on your needs. Our choices of packaging can be tailored to suit your particular requirements.
In the field of winemaking, we have recently taken our customer service program a step further. After adding an oenologist to our Q& A team and providing our customers with in-house lab services and consultation on an individual basis, we then engaged two internationally renowned oenologists as part of our consulting team, in order to advise our customers, keep them informed through symposiums and publications plus provide hands-on consultation directly at their cellars worldwide.